• Explore /
  • Poster
  • / A phase II study of talimogene laherparepvec (T-VEC) and pembrolizumab in patients with advanced sarcoma: Results of expansion cohorts.

A phase II study of talimogene laherparepvec (T-VEC) and pembrolizumab in patients with advanced sarcoma: Results of expansion cohorts.

Abstract Poster

Authors

null

Ciara Marie Kelly

Memorial Sloan Kettering Cancer Center, New York, NY

Ciara Marie Kelly , Viswatej Avutu , Ping Chi , Mark Andrew Dickson , Mrinal M. Gounder , Mary Louise Keohan , Sujana Movva , Evan Rosenbaum , Emma Cordover , Charlotte Eielson Ariyan , Edmund Bartlett , Aimee Marie Crago , Samuel Singer , Cristina R. Antonescu , Sinchun Hwang , Joseph Patrick Erinjeri , Kenneth Seier , Li-Xuan Qin , William D. Tap , Sandra P. D'Angelo

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Sarcoma

Track

Sarcoma

Sub Track

Soft Tissue Tumors

Clinical Trial Registration Number

NCT03069378

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr 11570)

DOI

10.1200/JCO.2023.41.16_suppl.11570

Abstract #

11570

Poster Bd #

504

Abstract Disclosures

Similar Posters

First Author: Lorenza Rimassa

First Author: ANA Maria Arance Fernandez

First Author: Neal Shiv Chawla

First Author: Erlinda Maria Gordon